October 23, 2020October 23, 2020
Phase 2 Trial of Haduvio for Chronic Cough Due to IPF Again Enrolling in UK
News
A Phase 2 study of Haduvio (nalbuphine extended release tablets) to treat chronic cough in people with idiopathic pulmonary ... Read more
October 22, 2020October 22, 2020
Telehealth ‘Helpful’ Alternative to In-person Care, Rare Disease Patients Say
News, syndicated
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like ... Read more
October 21, 2020October 21, 2020
Ultrasound Approach May Offer Safer, Less Costly Way of Diagnosing IPF
News
A new way of assessing ultrasound, a non-invasive technique using sound waves to produce pictures inside of the body, ... Read more
October 20, 2020October 20, 2020
Trial to Test Higher Dose of Inhaled Pirfenidone in All Participants
News
All patients in a Phase 1/2 trial examining two doses of AP01, an inhaled version of pirfenidone for the treatment ... Read more
October 19, 2020October 19, 2020
Phase 2 Trial of NP-120 for IPF Reaches 25% of Enrollment Target
News
A Phase 2 study of NP-120 (ifenprodil) for chronic cough associated with idiopathic pulmonary fibrosis (IPF) has reached 25% of ... Read more
October 16, 2020October 14, 2020
Mental Healthcare Is Important When Chronically Ill or Caregiving
Columns, Courage to Care - a column by Christie Patient
Oct. 10 was World Mental Health Day. I am a bit late to the party, but with a twice-monthly ... Read more
October 16, 2020October 16, 2020
Spred2 Gene Plays Possible Role in PF Development, Mouse Study Finds
News
A protein-coding gene called Spred2 may contribute to pulmonary fibrosis (PF) development, potentially representing a new therapeutic target, according ... Read more
October 15, 2020October 13, 2020
Avoid Toxic Positivity to Help PF Patients
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
I began hearing the term “toxic positivity” this year, and the pandemic has illuminated the term’s meaning for me. ... Read more
October 14, 2020October 14, 2020
Inhalable Signaling Protein BMP4 May Be Potential Treatment Approach for IPF
News
Treatment with inhalable bone morphogenic protein 4 (BMP4) — a soluble signaling molecule involved in the regulation of cellular ... Read more
October 13, 2020October 13, 2020
Large Chest Lymph Nodes in IPF Patients Tied in Study to Higher Risk of Mortality
News
People with idiopathic pulmonary fibrosis (IPF) who have three or more abnormally large lymph nodes in the area ... Read more
October 12, 2020October 12, 2020
Esbriet Treatment Seems Safe in IPF Patients With Lung Cancer, Study Reports
News
Esbriet (pirfenidone), an approved treatment for idiopathic pulmonary fibrosis (IPF), seems to be safe in IPF patients who also ... Read more
October 9, 2020October 9, 2020
Continuous Blood Filtration Shows Potential for Treating Paraquat-induced PF
News
Continuous hemoperfusion, a technique used to filter toxins from blood, was effective in improving the survival rates of people ... Read more

October 23, 2020October 23, 2020

Phase 2 Trial of Haduvio for Chronic Cough Due to IPF Again Enrolling in UK

News

A Phase 2 study of Haduvio (nalbuphine extended release tablets) to treat chronic cough in people with idiopathic pulmonary fibrosis (IPF) is again enrolling eligible patients, Trevi Therapeutics, the therapy’s developer, ... Read more

October 22, 2020October 22, 2020

Telehealth ‘Helpful’ Alternative to In-person Care, Rare Disease Patients Say

News, syndicated

A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like the option of continuing its use in future appointments, a ... Read more

October 21, 2020October 21, 2020

Ultrasound Approach May Offer Safer, Less Costly Way of Diagnosing IPF

News

A new way of assessing ultrasound, a non-invasive technique using sound waves to produce pictures inside of the body, may be effective in diagnosing idiopathic pulmonary fibrosis (IPF), a study ... Read more

October 20, 2020October 20, 2020

Trial to Test Higher Dose of Inhaled Pirfenidone in All Participants

News

All patients in a Phase 1/2 trial examining two doses of AP01, an inhaled version of pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF), are switching to the higher dose ... Read more

October 19, 2020October 19, 2020

Phase 2 Trial of NP-120 for IPF Reaches 25% of Enrollment Target

News

A Phase 2 study of NP-120 (ifenprodil) for chronic cough associated with idiopathic pulmonary fibrosis (IPF) has reached 25% of its enrollment target, Algernon Pharmaceuticals, the therapy’s developer, has announced. “I ... Read more

October 16, 2020October 14, 2020

Mental Healthcare Is Important When Chronically Ill or Caregiving

Columns, Courage to Care - a column by Christie Patient

Oct. 10 was World Mental Health Day. I am a bit late to the party, but with a twice-monthly publishing schedule, this is my first opportunity to share a ... Read more

October 16, 2020October 16, 2020

Spred2 Gene Plays Possible Role in PF Development, Mouse Study Finds

News

A protein-coding gene called Spred2 may contribute to pulmonary fibrosis (PF) development, potentially representing a new therapeutic target, according to the results of a new study. Titled “Spred2-deficiency enhances ... Read more

October 15, 2020October 13, 2020

Avoid Toxic Positivity to Help PF Patients

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

I began hearing the term “toxic positivity” this year, and the pandemic has illuminated the term’s meaning for me. According to The Psychology Group in Fort Lauderdale, Florida, toxic ... Read more

October 14, 2020October 14, 2020

Inhalable Signaling Protein BMP4 May Be Potential Treatment Approach for IPF

News

Treatment with inhalable bone morphogenic protein 4 (BMP4) — a soluble signaling molecule involved in the regulation of cellular identity — restored lung regeneration and improved lung function in ... Read more

October 13, 2020October 13, 2020

Large Chest Lymph Nodes in IPF Patients Tied in Study to Higher Risk of Mortality

News

People with idiopathic pulmonary fibrosis (IPF) who have three or more abnormally large lymph nodes in the area of the lungs and heart — a condition known as mediastinal ... Read more

October 12, 2020October 12, 2020

Esbriet Treatment Seems Safe in IPF Patients With Lung Cancer, Study Reports

News

Esbriet (pirfenidone), an approved treatment for idiopathic pulmonary fibrosis (IPF), seems to be safe in IPF patients who also have non‐small cell lung cancer (NSCLC) when combined with cancer therapy. The ... Read more

October 9, 2020October 9, 2020

Continuous Blood Filtration Shows Potential for Treating Paraquat-induced PF

News

Continuous hemoperfusion, a technique used to filter toxins from blood, was effective in improving the survival rates of people with acute poisoning due to paraquat, an herbicide used in ... Read more